Telix Pharmaceuticals Limited Finance Income
Telix Pharmaceuticals Limited (TLPPF) reported Finance Income of $5.83 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Income Statement › Other Income
ifrs-full:FinanceIncome · last filed 2026-02-20
AUD
| Period end | Finance Income 12 month |
|---|---|
| 2024-12-31 | 10.86M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 1.02M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 1.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Finance Income 12 month |
|---|---|
| 2025-12-31 | $5.83M 20-F · filed 2026-02-20 |
| 2024-12-31 | $7.18M 20-F · filed 2026-02-20 |
| 2023-12-31 | $671.00K 20-F · filed 2026-02-20 |